Clinically, serum IL-6 levels increase in colorectal cancer patients relative to healthy controls, and is correlated with tumour size, suggesting its potential as a prognostic marker of tumour progression (Galizia et al, 2002; Chung and Chang, 2003). The gene discussed is IL6; the disease is neoplasm.